Putamen mitochondrial energy metabolism is highly correlated to emotional and intellectual impairment in schizophrenics

Neuropsychopharmacology

Volumn 22, Issue 3, 2000, Pages 284-292

  Prince, Jonathan A ^a   Harro, Jaanus ^b   Blennow, Kaj ^c   Gottfries, Carl G ^c   Oreland, Lars ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF TARTU   (Estonia)

^c Institute of Clinical Neuroscience   (Sweden)

Author keywords

Cytochrome c oxidase; D2; Dopamine; Mitochondria; Putamen; Receptor; Schizophrenia

Indexed keywords

CYTOCHROME C OXIDASE; DOPAMINE 2 RECEPTOR; RACLOPRIDE;

ARTICLE; BRAIN MITOCHONDRION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; ENERGY METABOLISM; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; INTELLECTUAL IMPAIRMENT; MOTOR DYSFUNCTION; NERVE CELL; OUTCOMES RESEARCH; PRIORITY JOURNAL; PUTAMEN; RECEPTOR BINDING; SCHIZOPHRENIA; TISSUE DISTRIBUTION;

AGED; AGED, 80 AND OVER; ELECTRON TRANSPORT COMPLEX IV; EMOTIONS; ENERGY METABOLISM; FEMALE; HUMANS; INTELLIGENCE; MALE; MIDDLE AGED; MITOCHONDRIA; PUTAMEN; RACLOPRIDE; RECEPTORS, DOPAMINE D2; REFERENCE VALUES; REGRESSION ANALYSIS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0033974589     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(99)00111-6     Document Type: Article

References (46)

1. Adolfsson R., Gottfries C.G., Nystrom L., Winblad B. Prevalence of dementia disorders in institutionalized Swedish old people. The work load imposed by caring for these patients. Acta Psychiat Scand. 63:1981;225-244.
2. Andreasen N.C., O'Leary D.S., Cizadlo T., Arndt S., Rezai K., Ponto L.L., Watkins G.L., Hichwa R.D. Schizophrenia and cognitive dysmetria. A positron-emission tomography study of dysfunctional prefrontal-thalamic-cerebellar circuitry Proc Nat Acad Sci USA. 93:1996;9985-9990.
3. Andreasen N.C., O'Leary D.S., Flaum M., Nopoulos P., Watkins G.L., Boles Ponto L.L., Hichwa R.D. Hypofrontality in schizophrenia. Distributed dysfunctional circuits in neuroleptic-naive patients Lancet. 349:1997;1730-1734.
4. Andreasen N.C. Linking mind and brain in the study of mental illnesses. A project for a scientific psychopathology Science. 275:1997;1586-1593.
5. Brown L.L., Schneider J.S., Lidsky T.I. Sensory and cognitive functions of the basal ganglia. Curr Opin Neurobiol. 7:1997;157-163.
6. Buchsbaum M.S., Haier R.J., Potkin S.G., Nuechterlein K., Bracha H.S., Katz M., Lohr J., Wu J., Lottenberg S., Jerabek P.A., Trenary M., Tafalla R., Reynolds C., Bunney W.E. Fontostriatal disorder of cerbral metabolism in never-medicated schizophrenics. Arch Gen Psychiat. 49:1992;935-942.
7. Buchsbaum M.S., Ingvar D.H., Kessler R., Waters R.N., Cappelletti J., van Kammen D.P., King A.C., Johnson J.L., Manning R.G., Flynn R.W., Mann L.S., Bunney W.E. Jr., Sokoloff L. Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia. Arch Gen Psychiat. 39:1982;251-259.
8. Burt D.R., Creese I., Snyder S.H. Antischizophrenic drugs. Chronic treatment elevates dopamine receptor binding in brain Science. 196:1977;326-328.
9. Carlsson M., Carlsson A. Interactions between glutamatergic and monoaminergic systems within the basal ganglia - Implications for schizophrenia and Parkinson's disease. Trends Neurosci. 13:1990;272-276.
10. Carlsson A., Hansson L.O., Waters N., Carlsson M.L. Neurotransmitter aberrations in schizophrenia. New perspectives and therapeutic implications Life Sci. 61:1997;75-94.
11. Casey D.E. Motor and mental aspects of extrapyramidal syndromes. Int Clin Psychopharmacol. 10:1995;105-114.
12. Cavelier L., Jazin E.E., Eriksson I., Prince J., Bave U., Oreland L., Gyllensten U. Decreased cytochrome-c oxidase activity and lack of age-related accumulation of mitochondrial DNA deletions in the brains of schizophrenics. Genomics. 29:1995;217-224.
13. DeLisi L.E., Holcomb H.H., Cohen R.M., Pickar D., Carpenter W., Morihisa J.M., King A.C., Kessler R., Buchsbaum M.S. Positron emission tomography in schizophrenic patients with and without neuroleptic medication. J Cereb Blood Flow Metab. 5:1985;201-206.
14. Downs T.R., Wilfinger W.W. Fluorometric quantification of DNA in cells and tissue. Anal Biochem. 131:1983;538-547.
15. Eastwood S.L., Burnet P.W., Harrison P.J. Striatal synaptophysin expression and haloperidol-induced synaptic plasticity. NeuroReport. 5:1994;677-680.
16. Farde L., Gustavsson J.P., Jonsson E. D2 dopamine receptors and personality traits. Nature. 385:1997;590.
17. Hevner R.F., Duff R.S., Wong-Riley M.T.T. Coordination of ATP production and consumption in brain. Parallel regulation of cytochrome oxidase and Na+,K+-ATPase Neurosci Lett. 138:1992;188-192.
18. Hindmarch I. Instrumental assessment of psychomotor functions and the effects of psychotropic drugs. Acta Psychiat Scand Suppl. 380:1994;49-52.
19. Holcomb H.H., Cascella N.G., Thaker G.K., Medoff D.R., Dannals R.F., Tamminga C.A. Functional sites of neuroleptic drug action in the human brain. PET/FDG studies with and without haloperidol Am J Psychiat. 153:1996;41-49.
20. Humphries C., Mortimer A., Hirsch S., de Belleroche J. NMDA receptor mRNA correlation with antemortem cognitive impairment in schizophrenia. NeuroReport. 7:1996;2051-2055.
21. King D.J. The effect of neuroleptics on cognitive and psychomotor function. Br J Psychiat. 157:1990;799-811.
22. Lepiku M., Rinken A., Järv J., Fuxe K. Kinetic evidence for isomerization of the dopamine receptor - raclopride complex. Neurochem Int. 28:1996;591-595.
23. Levy R., Friedman H.R., Davachi L., Goldman-Rakic P.S. Differential activation of the caudate nucleus in primates performing spatial and nonspatial working memory tasks. J Neurosci. 17:1997;3870-3882.
24. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J Biol Chem. 193:1951;265-275.
25. Mackay A.V., Iversen L.L., Rossor M., Spokes E., Bird E., Arregui A., Creese I., Synder S.H. Increased brain dopamine and dopamine receptors in schizophrenia. Arch Gen Psychiat. 39:1982;991-997.
26. Markwell M.A.C., Maas S.M., Biebar L.L., Tolbert N.E. A modification of the Lowry procedure to simplify protein determination in membrane and in protein samples. Anal Biochem. 87:1978;206-211.
27. Nordahl T.E., Kusubov N., Carter C., Salamat S., Cummings A.M., O'Shora-Celaya L., Eberling J., Robertson L., Huesman R.H., Jagust W., Budinger T.F. Temporal lobe metabolic differences in medication-free outpatients with schizophrenia via the PET-600. Neuropsychopharmacology. 15:1996;541-554.
28. Okubo Y., Suhara T., Suzuki K., Kobayashi K., Inoue O., Terasaki O., Someya Y., Sassa T., Sudo Y., Matsushima E., Iyo M., Tateno Y., Toru M. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature. 385(6617):1997;634-636.
29. Prince J.A., Blennow K., Gottfries C.G., Karlsson I., Oreland L. Mitochondrial function is differentially altered in the basal ganglia of chronic schizophrenics. Neuropsychopharmacology. 21:1999;372-379.
30. Prince J.A., Yassin M.S., Oreland L. Neuroleptic-induced mitochondrial enzyme alterations in the rat brain. J Pharm Exp Ther. 280:1997;261-267. a.
31. Prince J.A., Yassin M.S., Oreland L. A histochemical demonstration of altered cytochrome oxidase acitivty in the rat brain by neuroleptics. Eur Neuropsychopharmacol. 8:1998;1-6.
32. Prince J.A., Yassin M., Oreland L. Normalization of cytochrome-c oxidase activity in the rat brain by neuroleptics after chronic treatment with PCP or methamphetamine. Neuropharmacology. 36:1997;1665-1678. b.
33. Rago R., Mitchen J., Wilding G. DNA fluorometric assay in 96-well tissue culture plates using hoechst 33258 after cell lysis by freezing in distilled water. Anal Biochem. 191:1990;31-34.
34. Sabri O., Erkwoh R., Schreckenberger M., Owega A., Sass H., Buell U. Correlation of positive symptoms exclusively to hyperperfusion or hypoperfusion of cerebral cortex in never-treated schizophrenics. Lancet. 349:1997;1735-1739.
35. Saykin A.J., Gur R.C., Gur R.E., Mozley P.D., Mozley L.H., Resnick S.M., Kester D.B., Stafiniak P. Neuropsychological function in schizophrenia. Selective impairment in memory and learning. Arch Gen Psychiat. 48:1991;618-624.
36. Shenton M.E., Kikinis R., Jolesz F.A., Pollak S.D., LeMay M., Wible C.G., Hokama H., Martin J., Metcalf D., Coleman M., McCarley R.W. Abnormalities of the left temporal lobe and thought disorder in schizophrenia. A quantitative magnetic resonance imaging study. N Engl J Med. 327:1992;604-612.
37. Shihabuddin L., Buchsbaum M.S., Hazlett E.A., Haznedar M.M., Harvey P.D., Newman A., Schnur D.B., Spiegel-Cohen J., Wei T., Machac J., Knesaurek K., Vallabhajosula S., Biren M.A., Ciaravolo T.M., Luu-Hsia C. Dorsal striatal size, shape, and metabolic rate in never-medicated and previously medicated schizophrenics performing a verbal learning task. Arch Gen Psychiat. 55:1998;235-243.
38. Siegel B.V., Buchsbaum M.S., Bunney W.E. Jr., Gottschalk L.A., Haier R.J., Lohr J.B., Lottenberg S., Najafi A., Nuechterlein K.H., Potkin S.G. Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients. Am J Psychiat. 150:1993;1325-1336.
39. Singer V.L., Jones L.J., Yue S.T., Haugland R.P. Characterization of PicoGreen reagent and development of a fluorescence-based solution assay for double-stranded DNA quantitation. Anal Biochem. 249:1997;228-238.
40. Smith A.D., Bolam J.P. The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones. Trends Neurosci. 13:1990;259-265.
41. Stratta P., Mancini F., Mattei P., Daneluzzo E., Casacchia M., Rossi A. Association between striatal reduction and poor Wisconsin Card Sorting Test performance in patients with schizophrenia. Biol Psychiat. 42:1997;816-820.
42. Weinberger D.R., Gallhofer B. Cognitive function in schizophrenia. Int Clin Psychopharmacol. 12:1997;S29-S36.
43. Wong-Riley M. Changes in the visual system of monocularly sutured or enucleated cats demonstrable with cytochrome oxidase histochemistry. Brain Res. 171:1979;11-28.
44. Wong-Riley M. Cytochrome oxidase. An endogenous metabolic marker for neuronal activity TINS. 12:1989;94-101.
45. Wong-Riley M., Carrol E.W. Effect of impulse blockage on cytochrome oxidase activity in monkey visual system. Nature. 307:1984;262-264.
46. Yonetani T., Ray G. Studies on cytochrome oxidase. J Biol Chem. 240:1965;3392-3399.